Posted on 03/05/22
Lyme disease poses an increasing global threat, driven by climate change and increased human migration, say experts. While Lyme disease vaccines in development show promise, it’s still likely to be
Posted on 08/04/22
A treatment for Epstein Barr (EBV) has moved a step closer as researchers have identified a new potential pathway to target the virus. Scientists at the Wistar Institute have discovered
Posted on 21/03/22
Using genomic sequencing and machine learning, scientists have developed an antibiotic prescribing system that cuts resistance by half. They tested the new platform by providing personalised prescriptions for urinary tract
Posted on 22/02/22
US scientists at the University of California San Diego have developed a new tool that can predict if pairs of antibiotics will help or harm a patient, reducing risks and
Posted on 09/02/22
Scientists studying COVID-19 patients have identified vital biological mechanisms that can act as early-warning signs that a patient will develop ‘Long Covid’. The authors say that the presence of some
Posted on 01/02/22
Researchers have developed a new computer tool that uses SNPs to identify disease pathways. Known as VarSAn, the tool can spot DNA mutations in a patient’s sample and identify pathways
Posted on 21/01/22
At Biocentaur, we stay at the cutting edge of new development in diagnosing and treating Lyme disease. Our range of genetic tests is helping patients receive a fast and accurate
Posted on 22/12/21
During the past year, scientists have made incredible leaps in diagnosing and treating Lyme disease. We’ve seen a realistic vaccine candidate emerge and several new and exciting treatments with exciting
Posted on 10/12/21
84% of patients referred for Lyme disease treatment at a US facility had “no findings of active Lyme disease,” a new study has found. Instead, the majority of patients were
Posted on 29/11/21
Yale University scientists have developed a novel vaccine that offers protection against Lyme disease-causing bacteria and other tick-borne diseases. Using the same mRNA technology in COVID-19 vaccines, the vaccine has
